Mirati Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates

SAN DIEGO, Feb. 28, 2023 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial stage biotechnology company, today announced financial results for the fourth quarter and full year of 2022 along with recent corporate updates. “2022 was a momentous year for Mirati,…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks